<DOC>
	<DOCNO>NCT01384773</DOCNO>
	<brief_summary>Keratoconus pellucid marginal degeneration genetically base ocular condition post surgical ectasia iatrogenic condition . These disease characterize weaken front part eye cause thin distortion . This distortion result unevenness cornea produce progressive near-sightedness irregularity , cause loss vision use eyeglass . When eyeglass fail give enough vision , investigator use rigid contact lenses create artificial front eye surface . This improve visual acuity many patient although eventually fail either tolerated surface irregularity become severe reject . At stage usually thinning loss clarity eye . There treatment corneal transplantation , complex surgical procedure significant complication rate delay visual recovery . The treatment investigator wish perform strengthen front eye chemical reaction use light riboflavin . This technique study decade widely use throughout world . The FDA approve multicenter American clinical study analyze anticipation submission FDA PreMarket approval . Because progressive condition , investigator wish able offer limited basis patient need vision loss . Any treatment delay prevent corneal transplantation great benefit . The investigator believe evidence compelling treatment sole alternative surgical transplantation .</brief_summary>
	<brief_title>Progressive Keratoconus Ectasia Treatment Plan</brief_title>
	<detailed_description>Potential candidate undergo complete eye examination determine eligibility treatment . Eligible subject prepared treatment accordance instruction use UV-Xâ„¢ Illumination System Operator 's Manual , include administration riboflavin preoperative medication ( e.g . topical anesthetic ) . Prescriptions postoperative medication write postoperative instruction give subject review prior discharge . All subject follow-up examination 1 day , 1 week , 3 month 6 month .</detailed_description>
	<mesh_term>Keratoconus</mesh_term>
	<mesh_term>Dilatation , Pathologic</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Riboflavin</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<criteria>Subjects one eye meet follow criterion consider candidate treatment : For Keratoconus Post Refractive Surgery Ectasia : 1 . 16 year age old 2 . Having diagnosis keratoconus one follow change period 24 month less . 1 . An increase &gt; 1.00 D steep keratometry value ( sim K ) 2 . An increase &gt; 1.00 D regular astigmatism evaluate subjective manifest refraction 3 . A myopic shift ( decrease spherical equivalent ) &gt; 0.50 D subjective manifest refraction 4 . Documented decrease visual acuity associate irregular astigmatism topographic feature ectasia . 3 . Presence central inferior steepen Pentacam map . 4 . Axial topography consistent keratoconus 5 . Slit lamp finding associate keratoconus must document : Fleischer ring Vogt stria Corneal thin Corneal scar 6 . Contact Lens Wearers Only : Removal contact lenses require prior screen 7 . Signed write inform consent All subject meet follow criterion exclude treatment : 1 . No evidence progression . 2 . Excessively thin cornea . 3 . Previous ocular condition eye treat may predispose eye future complication , example : 1 . History corneal disease ( e.g. , herpes simplex , herpes zoster keratitis , recurrent erosion syndrome , corneal melt , corneal dystrophy , etc . ) 2 . Clinically significant corneal scar propose treatment zone 4 . A history chemical injury delay epithelial healing eye ( ) treat . 5 . A known sensitivity treatment medication 6 . Patients current condition , treat physician 's opinion , would interfere prolong epithelial healing .</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Keratoconus</keyword>
	<keyword>Ectasia</keyword>
	<keyword>UVA light</keyword>
	<keyword>riboflavin</keyword>
	<keyword>post-LASIK ( laser situ keratomileusis )</keyword>
	<keyword>pellucid marginal degeneration</keyword>
	<keyword>irregular astigmatism</keyword>
</DOC>